Rein Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Rein Therapeutics, Inc. (RNTX) reported Basic Shares Outstanding (Weighted Average) of 67.08 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 67.08M shares, a 177.35% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 30.35M shares, a 38.51% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 29.27M shares, a 34.91% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 26.36M shares, a 21.69% increase year-over-year.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 25.44M shares, a 41.84% increase from fiscal 2024.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 17.94M shares, a 290.09% increase from fiscal 2023.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 4.60M shares, a 1.31% increase from fiscal 2022.
- Rein Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 4.54M shares, a 2.23% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 67.08M shares 10-Q · filed 2026-08-14 | 48.82M shares 10-Q · filed 2026-08-14 | 42.23M shares derived: average of 3 quarters · filed 2026-08-14 | 38.27M shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | 30.35M shares 10-Q · filed 2026-05-15 | 29.81M shares derived: average of 2 quarters · filed 2026-05-15 | 28.66M shares derived: average of 3 quarters · filed 2026-05-15 | 27.54M shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | 29.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 27.81M shares derived: average of 2 quarters · filed 2026-03-26 | 26.60M shares derived: average of 3 quarters · filed 2026-08-14 | 25.44M shares 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 26.36M shares 10-Q · filed 2025-11-14 | 25.27M shares derived: average of 2 quarters · filed 2026-08-14 | 24.17M shares 10-Q · filed 2025-11-14 | 23.54M shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | 24.19M shares 10-Q · filed 2026-08-14 | 23.06M shares 10-Q · filed 2026-08-14 | 22.60M shares derived: average of 3 quarters · filed 2026-08-14 | 22.36M shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | 21.92M shares 10-Q · filed 2026-05-15 | 21.80M shares derived: average of 2 quarters · filed 2026-05-15 | 21.76M shares derived: average of 3 quarters · filed 2026-05-15 | 21.30M shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | 21.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 21.68M shares derived: average of 2 quarters · filed 2026-03-26 | 21.09M shares derived: average of 3 quarters · filed 2026-03-26 | 17.94M shares 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 21.66M shares 10-Q · filed 2025-11-14 | 20.79M shares derived: average of 2 quarters · filed 2025-11-14 | 16.69M shares 10-Q · filed 2025-11-14 | 13.66M shares derived: average of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | 19.91M shares 10-Q · filed 2025-08-14 | 14.17M shares 10-Q · filed 2025-08-14 | 10.99M shares derived: average of 3 quarters · filed 2025-08-14 | 9.38M shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 8.30M shares 10-Q · filed 2025-05-15 | 6.54M shares derived: average of 2 quarters · filed 2025-05-15 | 5.87M shares derived: average of 3 quarters · filed 2025-05-15 | 5.54M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 4.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | 4.66M shares derived: average of 2 quarters · filed 2025-04-07 | 4.62M shares derived: average of 3 quarters · filed 2025-04-07 | 4.60M shares 10-K · filed 2025-04-07 | |||
| 2023-09-30 | 4.54M shares 10-Q · filed 2024-11-14 | 4.54M shares derived: average of 2 quarters · filed 2024-11-14 | 4.54M shares 10-Q · filed 2024-11-14 | 4.54M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 4.54M shares 10-Q · filed 2024-08-14 | 4.54M shares 10-Q · filed 2024-08-14 | 4.54M shares derived: average of 3 quarters · filed 2024-08-14 | 4.54M shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 4.54M shares 10-Q · filed 2024-05-15 | 4.54M shares derived: average of 2 quarters · filed 2024-05-15 | 4.54M shares derived: average of 3 quarters · filed 2024-05-15 | 4.54M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 4.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | 4.54M shares derived: average of 2 quarters · filed 2024-04-15 | 4.54M shares derived: average of 3 quarters · filed 2024-04-15 | 4.54M shares 10-K · filed 2024-04-15 | |||
| 2022-09-30 | 4.54M shares 10-Q · filed 2023-10-13 | 90.82M shares 10-Q · filed 2022-11-01 | 4.54M shares derived: average of 2 quarters · filed 2023-10-13 | 4.54M shares 10-Q · filed 2023-10-13 | 90.77M shares 10-Q · filed 2022-11-01 | -58.31M shares derived: average of 4 quarters · filed 2023-10-13 | |
| 2022-06-30 | 4.54M shares 10-Q · filed 2023-08-11 | 90.82M shares 10-Q · filed 2022-08-15 | 4.54M shares 10-Q · filed 2023-08-11 | 90.75M shares 10-Q · filed 2022-08-15 | -79.27M shares derived: average of 3 quarters · filed 2023-08-11 | -36.81M shares derived: average of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | 4.53M shares 10-Q · filed 2023-05-08 | -121.17M shares derived: average of 2 quarters · filed 2023-05-08 | -50.60M shares derived: average of 3 quarters · filed 2023-05-08 | -15.33M shares derived: average of 4 quarters · filed 2023-05-08 | |||
| 2021-12-31 | -246.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -78.16M shares derived: average of 2 quarters · filed 2023-03-20 | -21.96M shares derived: average of 3 quarters · filed 2023-03-20 | 4.44M shares 10-K · filed 2023-03-20 | |||
| 2021-09-30 | 90.55M shares 10-Q · filed 2022-11-01 | 90.50M shares derived: average of 2 quarters · filed 2022-11-01 | 88.21M shares 10-Q · filed 2022-11-01 | ||||
| 2021-06-30 | 90.46M shares 10-Q · filed 2022-08-15 | 86.94M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |